{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:44:08Z","timestamp":1775598248857,"version":"3.50.1"},"reference-count":188,"publisher":"Wiley","issue":"18","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Induction of programmed cell demise against tumors that achieves selective targeting of the cancerous state without side effects on healthy tissues and cells is the most challenging therapeutic goal to eradicate cancer progression. In this regard, several BH3\u2010mimetic drugs have been designed to induce apoptosis in cancer cells with acceptable specificity and fewer adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>Taking all considerations into account, even the latest versions of \u2010BH3 mimetics or some other systemic anticancer drugs may affect platelets, mainly manifested by thrombocytopenia in cancer patients who are per se at major risk of hemostatic complications. This is mainly due to the fact that platelets, as anucleated cells, are more vulnerable to apoptosis, especially induced by earlier versions of BH3\u2010mimetics. On the other hand, the cancerous state, particularly in its aggressive conditions, is usually associated with the risk of thrombosis and thromboembolism. Therefore, given that some earlier versions of BH3\u2010mimetics have the potential to simultaneously damage platelets and cancer cells, they may be considered as a therapeutic choice for the treatment of cancer\u2010associated thrombosis (CAT). However, this is subject to the design of a specific platform of drug carriers that supports cancer targeting without interfering with other tissues and cells. The critical review presented here first provides an overview of the various BH3\u2010mimetic drugs available, highlighting ongoing development to enhance their safety and efficacy. Then, by introducing studies on the direct delivery of BH3\u2010mimetics, this review finally proposes an innovative approach for the \u201cconserved conveyance\u201d of drugs to effectively cotarget cancer cells and activated platelets at the site of CAT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Notably, the main advantage of the proposed drug delivery system presented here is its minimal interference with natural hemostasis, where the drug is expected to attack only tumor cells and CAT, without affecting circulating platelets required for physiological thrombus formation and proper hemostasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cam4.71270","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:54:59Z","timestamp":1758282899000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Critical Review on\n                    <scp>BH<\/scp>\n                    3 Mimetic Drugs and the Treatment of Cancer\u2010Associated Thrombosis (\n                    <scp>CAT<\/scp>\n                    ): A Proposed Design for a Drug Delivery System Capable of Simultaneously Targeting Tumor Cells and Activated Platelets"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1128-5649","authenticated-orcid":false,"given":"Mehran","family":"Ghasemzadeh","sequence":"first","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin","family":"Heidari","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal","family":"Naghinezhad","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Ghasemzadeh","sequence":"additional","affiliation":[{"name":"School of Medicine Iran University of Medical Sciences  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehteramolsadat","family":"Hosseini","sequence":"additional","affiliation":[{"name":"Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine  Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"e_1_2_17_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2013.07.006"},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12470"},{"key":"e_1_2_17_4_1","first-page":"68","article-title":"Expression of DR4, DR5, FAS, Caspase\u20108 and, DDIAS Genes in AML Patients","volume":"37","author":"Naghinezhad J.","year":"2023","journal-title":"Medical Journal of the Islamic Republic of Iran"},{"key":"e_1_2_17_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-022-01780-7"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.50"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.985363"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.52"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.25607.1"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.934032"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110750"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.97"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.01.037"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-344812"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12744"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1005659"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.553"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03500-6"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1845332"},{"key":"e_1_2_17_20_1","volume-title":"FDA Approves New Drug for Chronic Lymphocytic Leukemia in Patients With a Specific Chromosomal Abnormality","author":"Food U.","year":"2016"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2021.1856660"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2017.11.001"},{"issue":"1","key":"e_1_2_17_23_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13046-021-02157-5","article-title":"BH3\u2010Mimetics: Recent Developments in Cancer Therapy","volume":"40","author":"Townsend P. A.","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2021004"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-126946"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404719"},{"key":"e_1_2_17_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03144-y"},{"key":"e_1_2_17_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01234"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.07.001"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060463"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26579"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2020.1724276"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-742684"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-347849"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00153"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.01.021"},{"issue":"12","key":"e_1_2_17_37_1","first-page":"2782","article-title":"Bcl\u20102 Binds to and Inhibits Ryanodine Receptors","volume":"127","author":"Vervliet T.","year":"2014","journal-title":"Journal of Cell Science"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400780"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.765973"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21405"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja0650347"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12420"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5836"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(85)90027-7"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-1050"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm1001265"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm060460o"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709443104"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.561"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19830"},{"key":"e_1_2_17_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0140"},{"key":"e_1_2_17_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.08.027"},{"key":"e_1_2_17_54_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.144"},{"key":"e_1_2_17_55_1","first-page":"62","volume-title":"International Journal of Laboratory Hematology","author":"Ghasemzadeh M.","year":"2014"},{"key":"e_1_2_17_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402081"},{"key":"e_1_2_17_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0224-3"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.564108"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122624"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2004.02.020"},{"key":"e_1_2_17_61_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/231635"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109642"},{"key":"e_1_2_17_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00294-9"},{"key":"e_1_2_17_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr555"},{"key":"e_1_2_17_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-9999-7"},{"key":"e_1_2_17_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321175"},{"key":"e_1_2_17_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00797-1"},{"key":"e_1_2_17_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0364-5"},{"key":"e_1_2_17_69_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1575"},{"key":"e_1_2_17_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-03070-9"},{"key":"e_1_2_17_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2013.45"},{"key":"e_1_2_17_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.21"},{"key":"e_1_2_17_73_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108694"},{"key":"e_1_2_17_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115738"},{"key":"e_1_2_17_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0084-0"},{"key":"e_1_2_17_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.559"},{"key":"e_1_2_17_77_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0928"},{"key":"e_1_2_17_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-233304"},{"key":"e_1_2_17_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115759"},{"key":"e_1_2_17_80_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-398834"},{"key":"e_1_2_17_81_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5439-1"},{"key":"e_1_2_17_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01437-1"},{"key":"e_1_2_17_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyad027"},{"key":"e_1_2_17_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26771"},{"key":"e_1_2_17_85_1","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2022.13.4.4"},{"key":"e_1_2_17_86_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.222588"},{"key":"e_1_2_17_87_1","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212574"},{"key":"e_1_2_17_88_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-1276"},{"key":"e_1_2_17_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01195-4"},{"key":"e_1_2_17_90_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034819"},{"key":"e_1_2_17_91_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0777"},{"key":"e_1_2_17_92_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6OB00808A"},{"key":"e_1_2_17_93_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099191"},{"key":"e_1_2_17_94_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.993313"},{"key":"e_1_2_17_95_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde.12.37"},{"key":"e_1_2_17_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.041"},{"key":"e_1_2_17_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.05.016"},{"key":"e_1_2_17_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03705-y"},{"key":"e_1_2_17_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1632"},{"key":"e_1_2_17_100_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-130571"},{"key":"e_1_2_17_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25227"},{"key":"e_1_2_17_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008017"},{"key":"e_1_2_17_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28146"},{"key":"e_1_2_17_104_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046104"},{"key":"e_1_2_17_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.08.019"},{"key":"e_1_2_17_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-010-0133-z"},{"key":"e_1_2_17_107_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03151.x"},{"key":"e_1_2_17_108_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9090116"},{"key":"e_1_2_17_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.20265"},{"key":"e_1_2_17_110_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S341824"},{"key":"e_1_2_17_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.05.060"},{"key":"e_1_2_17_112_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9NR10673A"},{"key":"e_1_2_17_113_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr030441b"},{"key":"e_1_2_17_114_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.8b06237"},{"key":"e_1_2_17_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2010.02.026"},{"key":"e_1_2_17_116_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b11178"},{"key":"e_1_2_17_117_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071711"},{"key":"e_1_2_17_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.12.003"},{"key":"e_1_2_17_119_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201707948"},{"key":"e_1_2_17_120_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6800"},{"key":"e_1_2_17_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00167-4"},{"key":"e_1_2_17_122_1","first-page":"S941","article-title":"1528P Phase I Trial of the First\u2010In\u2010Class Agent CEND\u20101 in Combination With Gemcitabine and Nab\u2010Paclitaxel in Patients With Metastatic Pancreatic Cancer","volume":"31","author":"J\u00e4rvel\u00e4inen H.","year":"2000","journal-title":"Annals of Oncology"},{"key":"e_1_2_17_123_1","doi-asserted-by":"publisher","DOI":"10.3390\/polym12091906"},{"key":"e_1_2_17_124_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7ME00050B"},{"key":"e_1_2_17_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.10.013"},{"key":"e_1_2_17_126_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.8b04847"},{"key":"e_1_2_17_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116050"},{"key":"e_1_2_17_128_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S219820"},{"key":"e_1_2_17_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00602-5"},{"key":"e_1_2_17_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5778"},{"key":"e_1_2_17_131_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b06969"},{"key":"e_1_2_17_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.03.002"},{"key":"e_1_2_17_133_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020328"},{"key":"e_1_2_17_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111825"},{"key":"e_1_2_17_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.02.026"},{"key":"e_1_2_17_136_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100380"},{"key":"e_1_2_17_137_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03716-0"},{"key":"e_1_2_17_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04346.x"},{"key":"e_1_2_17_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.06.047"},{"key":"e_1_2_17_140_1","doi-asserted-by":"publisher","DOI":"10.1177\/096721090000800308"},{"key":"e_1_2_17_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-018-0635-x"},{"key":"e_1_2_17_142_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00102a020"},{"key":"e_1_2_17_143_1","doi-asserted-by":"publisher","DOI":"10.1159\/000046589"},{"key":"e_1_2_17_144_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.e14532"},{"key":"e_1_2_17_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(16)30101-3"},{"key":"e_1_2_17_146_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-018-0168-2"},{"key":"e_1_2_17_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00773-1"},{"key":"e_1_2_17_148_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1726298"},{"key":"e_1_2_17_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.002"},{"key":"e_1_2_17_150_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i18.4466"},{"key":"e_1_2_17_151_1","doi-asserted-by":"publisher","DOI":"10.5858\/2009-0114-OA.1"},{"key":"e_1_2_17_152_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-168"},{"key":"e_1_2_17_153_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702327200"},{"key":"e_1_2_17_154_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213093"},{"key":"e_1_2_17_155_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-933337"},{"key":"e_1_2_17_156_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-150318"},{"key":"e_1_2_17_157_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-317685"},{"key":"e_1_2_17_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920615)69:12<2884::AID-CNCR2820691204>3.0.CO;2-S"},{"key":"e_1_2_17_159_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003149"},{"key":"e_1_2_17_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.03.022"},{"key":"e_1_2_17_161_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-453498"},{"key":"e_1_2_17_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.08.030"},{"key":"e_1_2_17_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.02.036"},{"key":"e_1_2_17_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.07.054"},{"key":"e_1_2_17_165_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-459636"},{"issue":"3","key":"e_1_2_17_166_1","first-page":"133","article-title":"Different Stages of Platelet Adhesion to the Site of Vascular Injury","volume":"4","author":"Hosseini E.","year":"2012","journal-title":"Iranian Journal of Blood and Cancer"},{"key":"e_1_2_17_167_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH04-06-0340"},{"key":"e_1_2_17_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.02.033"},{"key":"e_1_2_17_169_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.133"},{"key":"e_1_2_17_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2018.01.038"},{"key":"e_1_2_17_171_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10856-023-06719-1"},{"key":"e_1_2_17_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54042-4"},{"key":"e_1_2_17_173_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm970832g"},{"key":"e_1_2_17_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep39805"},{"key":"e_1_2_17_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2009.12.023"},{"key":"e_1_2_17_176_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140713447"},{"key":"e_1_2_17_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.08.003"},{"key":"e_1_2_17_178_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0490-RA"},{"key":"e_1_2_17_179_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12110709"},{"key":"e_1_2_17_180_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006044"},{"key":"e_1_2_17_181_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13940"},{"key":"e_1_2_17_182_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18081-9"},{"key":"e_1_2_17_183_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.3_suppl.58S"},{"key":"e_1_2_17_184_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8835"},{"key":"e_1_2_17_185_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-019-0209-5"},{"key":"e_1_2_17_186_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-018-1739-6"},{"key":"e_1_2_17_187_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-261669"},{"key":"e_1_2_17_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.12.036"},{"key":"e_1_2_17_189_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01841-5"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.71270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T08:27:25Z","timestamp":1766219245000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.71270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":188,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/cam4.71270"],"URL":"https:\/\/doi.org\/10.1002\/cam4.71270","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2024-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e71270"}}